NCT06511154 The Effect of Cognitive Exercise on Upper Extremity Functions, Balance and Cognitive Functions in Multiple Sclerosis
| NCT ID | NCT06511154 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Yildirim Beyazıt University |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-05-13 |
| Primary Completion | 2025-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-05-13 with a primary completion date of 2025-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multiple sclerosis (MS) is a chronic, progressive, demyelinating disease characterized by myelin sheath damage in the central nervous system that affects more than 2.5 million people worldwide and is more common in young adults aged 20-40 years, especially in women. Like physical impairments, cognitive impairments are a common clinical finding in individuals with MS, both in the early and late stages of the disease. Individuals with MS with cognitive impairment have more difficulty than those without cognitive impairment in participating in social and occupational activities, finding a job, working and performing routine household activities. It is also known that there is a high percentage of individuals with MS with upper extremity involvement in the early stages of the disease. Functional problems in the upper extremities lead to restriction of activity and participation in individuals with MS. Although it is stated that there is a high rate of upper extremity problems in individuals with MS, it is seen that they are not sufficiently understood and analyzed. When the literature is examined; evidence-based studies examining the effect of cognitive exercise on motor functions in MS in addition to physical exercises are quite limited. In this context, the subject of this study is to examine the effect of cognitive rehabilitation on upper extremity functions, balance and cognitive functions in individuals with MS.
Eligibility Criteria
Inclusion Criteria: * Being between the ages of 18 and 65 * A definitive diagnosis of MS by a neurologist * Having an Expanded Disability Status Scale (EDSS) score below 5.5 * No cognitive problems (Mini Mental Test score of 24 and above), * Graduated from at least primary school * No change in medical treatment in the last 6 months, * Not having had an attack in the last 3 months and not using pulse steroid therapy * Volunteering. Exclusion Criteria: * Having hearing and vision problems that prevent communication * Having a neurological or psychiatric disease other than MS that causes cognitive impairment * Pregnancy * Oncological diseases * Having other vestibular and orthopedic diseases that may affect balance * Continue with a different exercise therapy
Contact & Investigator
Emine İpek Halatcı, MSc
PRINCIPAL INVESTIGATOR
Ankara Yildirim Beyazıt University
Frequently Asked Questions
Who can join the NCT06511154 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06511154 currently recruiting?
Yes, NCT06511154 is actively recruiting participants. Contact the research team at emnepek@gmail.com for enrollment information.
Where is the NCT06511154 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06511154 clinical trial?
NCT06511154 is sponsored by Ankara Yildirim Beyazıt University. The principal investigator is Emine İpek Halatcı, MSc at Ankara Yildirim Beyazıt University. The trial plans to enroll 32 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.